Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Kathleen Cooney

GU Oncology · Duke

View

Dr. Rebecca Shatsky

Breast Oncology · UCSD

View

Dr. Robert Bast

Breast Oncology · MD Anderson Cancer Center

View

Dr. Julia Close

General Oncology · UF

View

Dr. Sara Tolaney

Breast Oncology · Dana-Farber Cancer Institute

View

Dr. Allison Fitzgerald

General Oncology · Dana-Farber Cancer Institute

View

Dr. Jason Mouabbi

Breast Oncology · MD Anderson Cancer Center

View

Dr. Rebecca Miksad

GI Oncology · BMC

View

Dr. Lee Scheinbart

General Oncology · Burrell College of Osteopathic Medicine

View

Dr. Matthew Kurian

Breast Oncology · St Elizabeth Healthcare

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    JKDr. Joshua Kassner

    Dr. Joshua Kassner

    Medical Oncology · Myeloma
    Weill Cornell Medicine
    joshuak

    Research

    PA-400 Real-World Outcomes and Predictors of Bispecific Antibody Therapy Response in a Racially Diverse Multiple Myeloma Cohort

    2026

    Via Clinical Lymphoma Myeloma & Leukemia

    Research

    PA-351 Phase II Study of Daratumumab, Clarithromycin, Pomalidomide, and Dexamethasone (D-ClaPd) in Multiple Myeloma Patients Previously Exposed to Daratumumab

    2026

    Via Clinical Lymphoma Myeloma & Leukemia

    Research

    OA-02 A CD4 Dominant, T-Helper-Skewed T Cell State Underlies Movement and Neurocognitive Toxicity After BCMA-Directed CAR-T Therapy in Multiple Myeloma

    2026

    Via Clinical Lymphoma Myeloma & Leukemia

    Research

    Anakinra Prophylaxis during BCMA-Directed CAR-T Therapy: A Two-Center Analysis of Toxicity and Outcomes

    2026

    Via Transplantation and Cellular Therapy

    Research

    Response and outcomes of patients with IDH1/2- mutated accelerated/blast-phase myeloproliferative neoplasms

    2025

    Via Blood Neoplasia

    Research

    Assessing AML-based risk criteria in patients with accelerated/blast-phase MPN treated with less-intensive therapy

    2025

    Via Blood Advances

    Research

    Current landscape of CD3 bispecific antibodies in hematologic malignancies

    2024

    Via Trends in Cancer

    Research

    Outcomes of Patients with Accelerated/Blast-Phase MPNs That Received Allogeneic Stem-Cell Transplant in the Current Era of Myeloid Therapies

    2023

    Via Blood